Treatment with a new antidiabetic: glybenclamide
Madsen, S.N.; Persson, I.
Ugeskrift for Laeger 132(4): 143-147
1970
ISSN/ISBN: 0041-5782 PMID: 5442953 Document Number: 26809
Document emailed within 1 workday
Related Documents
Schroner, Z.; Javorsky, M.; Kozarova, M.; Tkac, I. 2011: Pharmacogenetics of oral antidiabetic treatment Bratislavske Lekarske Listy 112(8): 441-446Schumm-Draeger, P-Maria. 2006: Current treatment with oral antidiabetic agents MMW Fortschritte der Medizin 148(9): 33-35
Pandya, J.K.; Jhala, C.I.; Goel, R.K. 1983: Antidiabetic treatment and coxsackie virus in diabetes Indian Journal of Pathology and Microbiology 26(2): 71-75
Behpour, A. 1980: Diabetes in adults and old age. Treatment with an oral antidiabetic agent Zfa. Zeitschrift für Allgemeinmedizin 56(22): 1412-1414
Karásek, D. 2017: The effect of antidiabetic treatment on the bone of patients with type 2 diabetes Vnitrni Lekarstvi 62(7-8): 582-587
Pálossy, B.; Góth, M. 1977: Clinical observations with glybenclamide (Gilemal) Therapia Hungarica 25(4): 162-165
Saxena, K.K.; Lata, S.; Saxena, R.S.; Kumar, A.; Srivastava, V.K. 1990: Modification of glybenclamide hypoglycaemia by verapamil in rabbits Indian Journal of Physiology and Pharmacology 34(4): 277-278
Chhetri, M.K.; Das, M.R.; Pal, K.C. 1970: Clinical experience with glybenclamide in diabetes mellitus Journal of the Indian Medical Association 55(12): 413-415
Fabian, Wława.; Majkowska, L.; Stefański, A.; Moleda, P. 2005: Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners Przeglad Lekarski 62(4): 201-205
Weber, B.; Hahn, W. 1970: Blood sugar and plasma insulin levels in children following the oral administration of glybenclamide (HB 419) Zeitschrift für Kinderheilkunde 108(1): 32-40
Thomas Schöndorf; Forst, T.; Flohberg, C.; Georg Lübben; Armbruster, F.P.; Roth, W.; Borchert, M.; Christiane Köder; Mirjam Löbig; Grabellus, M.; Pf, A.ützner 2007: Relaxin Expression Correlates Significantly with Serum Changes in VEGF in Response to Antidiabetic Treatment in Male Patients with Type 2 Diabetes mellitus Clinical Laboratory 53(3-4): 193-198
Lavieuville, M.; Isnard, F. 1978: Focus on antidiabetic biguanides Journees Annuelles de Diabetologie de l'Hotel-Dieu 1978: 341-346
Johansen, K. 2001: New oral antidiabetic glitazones Ugeskrift for Laeger 164(1): 76-77
Hepp, K.D. 1983: Fenfluramine as an oral antidiabetic Münchener Medizinische Wochenschrift 125(46): 126-127
Kostenbauder, H.B. 2008: Initiating antidiabetic drug therapy Clinical Therapeutics 30(5): 986; Author Reply 986-7
Kawanami, D.; Utsunomiya, K. 2015: Transition and perspectives of antidiabetic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 375-381
Dzhafarova, R.E.; Garaev, G.S.; Dzhafarkulieva, Z.S. 2009: Antidiabetic action of extract of Juglans regia L Georgian Medical News 170: 110-114
Muzhanovskiĭ, E.B.; Fartushnyĭ, A.F.; Sukhin, A.P.; Sedov, A.I. 1990: The forensic chemical determination of antidiabetic agents Sudebno-Meditsinskaia Ekspertiza 33(2): 38-40
Haslbeck, M. 1979: New aspects of therapy with oral antidiabetic agents Wiener Medizinische Wochenschrift 199(24): 689-695
Koivisto, V. 1999: Insulin analogs and new oral antidiabetic drugs Duodecim; Laaketieteellinen Aikakauskirja 115(20): 2197-2202